MOONEY PATRICK T 4
4 · Echo Therapeutics, Inc. · Filed Mar 2, 2011
Insider Transaction Report
Form 4
MOONEY PATRICK T
DirectorCEO and President
Transactions
- Award
Common Stock
2011-02-28+350,000→ 2,200,907 total
Footnotes (1)
- [F1]The shares shall vest upon the first to occur of (i) FDA approval of the Companys Symphony tCGM System; or (ii) the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for liquid proceeds, which was defined as (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days; or (d) or a combination of cash and the foregoing securities.